newsfilter
← Latest News
ClinicalTrials.gov·

Phase 1/2 Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA - NCT05778877

Safety and tolerability of SEL-302, PD Activity of SEL-302, Assess the change in Neutralizing antibody (Nab) titers for MMA-101 with treatment of SEL-110, (and 5 more...)